61 related articles for article (PubMed ID: 22619049)
21. Inactivation of the CDKN2A tumor-suppressor gene by deletion or methylation is common at diagnosis in follicular lymphoma and associated with poor clinical outcome.
Alhejaily A; Day AG; Feilotter HE; Baetz T; Lebrun DP
Clin Cancer Res; 2014 Mar; 20(6):1676-86. PubMed ID: 24449825
[TBL] [Abstract][Full Text] [Related]
22. Characteristics and outcomes of patients with CLL and CDKN2A/B deletion by fluorescence in situ hybridization.
Teierle SM; Huang Y; Kittai AS; Bhat SA; Grever M; Rogers KA; Zhao W; Jones D; Byrd JC; Avenarius MR; Heerema NA; Woyach JA; Miller CR
Blood Adv; 2023 Dec; 7(23):7239-7242. PubMed ID: 37851900
[No Abstract] [Full Text] [Related]
23. Infiltrative Rash Secondary to Leukemic-Phase Diffuse Large B-Cell Lymphoma With t(14;18), CDKN2A and MLL Deletion.
Sheng IY; Treaba DO; Bishop KD
J Hematol; 2017 Oct; 6(4):90-95. PubMed ID: 32300400
[TBL] [Abstract][Full Text] [Related]
24. Characterization of genomic alterations in primary central nervous system lymphomas.
Zorofchian S; El-Achi H; Yan Y; Esquenazi Y; Ballester LY
J Neurooncol; 2018 Dec; 140(3):509-517. PubMed ID: 30171453
[TBL] [Abstract][Full Text] [Related]
25. p16 Tumor Suppressor Gene Methylation in Diffuse Large B Cell Lymphoma: A Study of 88 Cases at Two Hospitals in the East Coast of Malaysia.
Mohd Ridah LJ; A Talib N; Muhammad N; Hussain FA; Zainuddin N
Asian Pac J Cancer Prev; 2017 Oct; 18(10):2781-2785. PubMed ID: 29072413
[TBL] [Abstract][Full Text] [Related]
26. Clinical significance of
Ren Y; Xiao L; Weng G; Shi B
Oncotarget; 2017 Sep; 8(38):64385-64394. PubMed ID: 28969078
[TBL] [Abstract][Full Text] [Related]
27. Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive review.
Camicia R; Winkler HC; Hassa PO
Mol Cancer; 2015 Dec; 14():207. PubMed ID: 26654227
[TBL] [Abstract][Full Text] [Related]
28. Clinical significance of methylation of E-cadherin and p14ARF gene promoters in skin squamous cell carcinoma tissues.
Wu J; Zhang JR; Qin J
Int J Clin Exp Med; 2014; 7(7):1808-12. PubMed ID: 25126184
[TBL] [Abstract][Full Text] [Related]
29. Enhanced serum methylated p16 DNAs is associated with the progression of gastric cancer.
Wu YC; Lv P; Han J; Yu JL; Zhu X; Hong LL; Zhu WY; Yu QM; Wang XB; Li P; Ling ZQ
Int J Clin Exp Pathol; 2014; 7(4):1553-62. PubMed ID: 24817951
[TBL] [Abstract][Full Text] [Related]
30. Hypermethylation of p15 gene in diffuse - large B-cell lymphoma: association with less aggressiveness of the disease.
Krajnović M; Jovanović MP; Mihaljević B; Anđelić B; Tarabar O; Knežević-Ušaj S; Krtolica K
Clin Transl Sci; 2014 Oct; 7(5):384-90. PubMed ID: 24815848
[TBL] [Abstract][Full Text] [Related]
31. How we treat Richter syndrome.
Parikh SA; Kay NE; Shanafelt TD
Blood; 2014 Mar; 123(11):1647-57. PubMed ID: 24421328
[TBL] [Abstract][Full Text] [Related]
32. Variability in DNA methylation defines novel epigenetic subgroups of DLBCL associated with different clinical outcomes.
Chambwe N; Kormaksson M; Geng H; De S; Michor F; Johnson NA; Morin RD; Scott DW; Godley LA; Gascoyne RD; Melnick A; Campagne F; Shaknovich R
Blood; 2014 Mar; 123(11):1699-708. PubMed ID: 24385541
[TBL] [Abstract][Full Text] [Related]
33. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of p14ARF, p15INK4b, and p16INK4a inactivation in malignant peripheral nerve sheath tumors.
Endo M; Kobayashi C; Setsu N; Takahashi Y; Kohashi K; Yamamoto H; Tamiya S; Matsuda S; Iwamoto Y; Tsuneyoshi M; Oda Y
Clin Cancer Res; 2011 Jun; 17(11):3771-82. PubMed ID: 21262917
[TBL] [Abstract][Full Text] [Related]
35. Islet biology, the CDKN2A/B locus and type 2 diabetes risk.
Kong Y; Sharma RB; Nwosu BU; Alonso LC
Diabetologia; 2016 Aug; 59(8):1579-93. PubMed ID: 27155872
[TBL] [Abstract][Full Text] [Related]
36. The Yin and Yang-Like Clinical Implications of the
González-Gil C; Ribera J; Ribera JM; Genescà E
Genes (Basel); 2021 Jan; 12(1):. PubMed ID: 33435487
[TBL] [Abstract][Full Text] [Related]
37. Several mechanisms lead to the inactivation of the CDKN2A (P16), P14ARF, or CDKN2B (P15) genes in the GCB and ABC molecular DLBCL subtypes.
Guney S; Jardin F; Bertrand P; Mareschal S; Parmentier F; Picquenot JM; Tilly H; Bastard C
Genes Chromosomes Cancer; 2012 Sep; 51(9):858-67. PubMed ID: 22619049
[TBL] [Abstract][Full Text] [Related]
38. Molecular characterization of 9p21 deletions shows a minimal common deleted region removing CDKN2A exon 1 and CDKN2B exon 2 in diffuse large B-cell lymphomas.
Guney S; Bertrand P; Jardin F; Ruminy P; Kerckaert JP; Tilly H; Bastard C
Genes Chromosomes Cancer; 2011 Sep; 50(9):715-25. PubMed ID: 21638516
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
